3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru-II(arene) anticancer complexes with biologically active ligands

Author(s)
Andrea Kurzwernhart, Wolfgang Kandioller, Eva Anna Enyedy, Maria Novak, Michael Jakupec, Bernhard Keppler, Christian G. Hartinger
Abstract

Ru-II(eta(6)-arene) complexes, especially with bioactive ligands, are considered to be very promising compounds for anticancer drug design. We have shown recently that Ru-II(eta(6)-p-cymene) complexes with 3-hydroxyflavone ligands exhibit very high in vitro cytotoxic activities correlating with a strong inhibition of topoisomerase II alpha. In order to expand our knowledge about the structure-activity relationships and to determine the impact of lipophilicity of the arene ligand and of the hydrolysis rate on anticancer activity, a series of novel 3-hydroxyflavone derived Ru-II(eta(6)-arene) complexes were synthesised. Furthermore, the impact of the heteroatom in the bioactive ligand backbone was studied by comparing the cytotoxic activity of Ru-II(eta(6)-p-cymene) complexes of 3-hydroxyquinolinone ligands with that of their 3-hydroxyflavone analogues. To better understand the behaviour of these Ru-II complexes in aqueous solution, the stability constants and pK(a) values for complexes and the corresponding ligands were determined. Furthermore, the interaction with the DNA model 5'-GMP and with a series of amino acids was studied in order to identify potential biological target structures.

Organisation(s)
Department of Inorganic Chemistry
External organisation(s)
University of Szeged, University of Auckland
Journal
Dalton Transactions
Volume
42
Pages
6193-6202
No. of pages
10
ISSN
1477-9226
DOI
https://doi.org/10.1039/c2dt32206d
Publication date
2013
Peer reviewed
Yes
Austrian Fields of Science 2012
104003 Inorganic chemistry, 301207 Pharmaceutical chemistry
Portal url
https://ucrisportal.univie.ac.at/en/publications/e4976ce3-8be5-41b5-96e8-a3e072365aa1